Your browser doesn't support javascript.
loading
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis.
El-Naggar, Amal M; Somasekharan, Syam Prakash; Wang, Yemin; Cheng, Hongwei; Negri, Gian Luca; Pan, Melvin; Wang, Xue Qi; Delaidelli, Alberto; Rafn, Bo; Cran, Jordan; Zhang, Fan; Zhang, Haifeng; Colborne, Shane; Gleave, Martin; Mandinova, Anna; Kedersha, Nancy; Hughes, Christopher S; Surdez, Didier; Delattre, Olivier; Wang, Yuzhuo; Huntsman, David G; Morin, Gregg B; Sorensen, Poul H.
Afiliación
  • El-Naggar AM; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Somasekharan SP; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
  • Wang Y; Department of Pathology, Faculty of Medicine, Menoufia University, Shibin El Kom, Egypt.
  • Cheng H; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Negri GL; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
  • Pan M; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Wang XQ; Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
  • Delaidelli A; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
  • Rafn B; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
  • Cran J; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Zhang F; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
  • Zhang H; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
  • Colborne S; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
  • Gleave M; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Mandinova A; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Kedersha N; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
  • Hughes CS; Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
  • Surdez D; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Delattre O; Brigham and Women's Hospital, Harvard University, Boston, MA, USA.
  • Wang Y; Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Huntsman DG; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
  • Morin GB; Centre de recherche de l'Institut Curie, Paris, France.
  • Sorensen PH; Centre de recherche de l'Institut Curie, Paris, France.
EMBO Rep ; 20(12): e48375, 2019 12 05.
Article en En | MEDLINE | ID: mdl-31668005
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Sarcoma de Ewing / Factores de Transcripción / Benzamidas / Neoplasias Óseas / Inhibidores de Histona Desacetilasas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: EMBO Rep Asunto de la revista: BIOLOGIA MOLECULAR Año: 2019 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Sarcoma de Ewing / Factores de Transcripción / Benzamidas / Neoplasias Óseas / Inhibidores de Histona Desacetilasas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: EMBO Rep Asunto de la revista: BIOLOGIA MOLECULAR Año: 2019 Tipo del documento: Article País de afiliación: Canadá